Aberdeen Group plc Increases Stake in Codexis, Inc. to 7.45%

2026-07-20SEC Filing SCHEDULE 13G/A (0001716774-26-000018)

On July 20, 2026, Aberdeen Group plc and its subsidiary abrdn Inc. filed a Schedule 13G/A with the SEC, reporting a significant stake in Codexis, Inc. (CDXS). The filing indicates that the group now beneficially owns 6,769,954 shares of Common Stock, representing 7.45% of the company's total outstanding shares. This reflects an increase in holdings compared to previous filings where the ownership was not previously established at this level. The reported shares are held by Aberdeen Group plc as a parent holding company, with abrdn Inc. acting as the investment adviser and intermediate holding company managing these assets on behalf of underlying clients. The reporting entities disclosed shared voting and dispositive power over all 6,769,954 shares. The filing was made under Rule 13d-1(b), certifying that the securities were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. The event triggering this filing occurred on June 30, 2026.

Ticker mentioned:CDXSInstitution mentioned:Aberdeen Group plc
Related industry:Biotechnology